Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
30 Cards in this Set
- Front
- Back
metastasos
|
single/group of cells break off from primary tumor and seed some other tumor
|
|
malignancy:
|
capacity to invade surrounding tissue. benign tumore has a defined edge
|
|
where do cancers arise from?
|
a single cell-- clocal
|
|
2 properties that define cancer cells
|
1. have escaped normal constraints of growth control and thus proliferate out of control
2. invade and colonize areas of the body normally occupied by other cells |
|
ex of heritable changes
|
genetic
epigenetic |
|
genetic
|
alterations in the DNA of cell
|
|
epigenetic
|
changes in tehpattern of cellular gene expression withouut changes in teh DNA sequences
|
|
3 classes of cancer causing agents
|
chemical carcinogens
UV and ionizing radiation viruses |
|
what kinds of viruses have the potential to cause cancer?
|
DNA
usually RNA b/c they have reverse tran scriptase to turn RNA into DNA |
|
sources of tumor antigens
|
after cell undergoes mutation, it may present mutant peptide
|
|
NK cells and recognition
|
NK cells recognize that cancer cells don't have MHC Class I (NK cells activated by lack of these)
NK cells recognize receptors on the surface of cancer cells |
|
what happens once NK cells are activated?
|
IFN gammais produced --> macrophages, DC, increase in MHC Class II, I and CD80/86
|
|
T cell response to tumors
|
CD8 T cells can be induced by cross priming by APCs which have processed tumor cells.
IFN is v imp |
|
tumor escape mechanisms
|
induction of tolerance
expression of FasL or TNF lack of costim molec production of TGF beta or IL-10 induce non cytolytic Abs that msk TUmor Ags produce substances that mask tumor Ags |
|
immune priveledged sites
|
locations in body where immune response to antigens is not destructive or is suppressed
|
|
examples of immune priveleged sites
|
brain
testis |
|
effect of latering MHC Class I expresing on CTL and NK cell killing
|
when MHC Class I is expressed, CTL kill, when not expressed-- opposite
|
|
tumor cells must have the ability to----
|
stimulate angiogenesis
|
|
myeloid derived suppressor cels
|
are alternately activated macrophages they decreases production of IL-12
IL-12 is involved with developemtn of TH1 which makes IL-2 which stimulates CD8 T cells |
|
CTLA4
|
downregulates activation of T cells
|
|
IL-17
|
proinflammatory
but also induces angiogenesis tthat helps tumore cells smetastasize |
|
gm-csf
|
powerful growth factor for the development of a DC
|
|
tumor cell transfection to enhance IR
|
by vaccinating with tumor cell expressing costim or IL-2
IL-2 will enhanve proliferation and differentiation of tumor-specific T cells costim molec witll activate tumor specific T cell |
|
anti tumor monoclonal Ab
|
transfer of these antibodies with toxic substances attach helps target drugs
|
|
why are attentuated better than dead vaccines
|
a killed/inactivated pathogen won't infect cells, so it won't stimulate TLR ery well
|
|
features of effective vaccines
|
safe
protective gives sustained protection induces neutralizing antibody induces protective T cells practical considerations |
|
advantages of live attenuated vaccines
|
limited viral replication which can be a good stimulus to the immune system
progeny virions are often contained at the site of infection , which both limits spread and has an adjuvant effect infection induces a mild/subclinicaldiesase |
|
disadvan of live attenutated vaccines
|
reversion to wt virulence by mutation of virus
recombination with other viruses giving rise to a new virulent strain of virus virsu can also be contracted |
|
adjuvants
|
activate an inflammatory response by throwing something to activate TLR --> better innate response
|
|
ISCOM: immune stimulating complexes
|
lipid micelles that contain viral peptides
way of directly loading cells with specific proteins activate CD8 T cells |